Brian Larsen Thorsted

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial

Exploring the characteristics of suboptimally controlled patients after 24 weeks of basal insulin treatment: An individualized approach to intensification

The Cardiovascular Biology of Glucagon-like Peptide-1

Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function

Sphingolipids and their metabolism in physiology and disease

Diabetes Care in Iran: Where We Stand and Where We Are Headed

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population

Exercise and Postprandial Glycemic Control in Type 2 Diabetes

Type 2 diabetes

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies

Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?

An observational study of patient characteristics and mortality following hypoglycemia in the community

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Minimizing Hypoglycemia in Diabetes

Pathophysiology of Type 2 Diabetes Mellitus

Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases

Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis

Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit

Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus

Global burden of heart failure: a comprehensive and updated review of epidemiology

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

Clinical Inertia in People With Type 2 Diabetes